Merck receives EU CHMP positive opinion for investigational V920 Ebola Zaire vaccine for protection against Ebola virus disease

18 October 2019 - Merck today announced that the CHMP of the EMA has adopted a positive opinion recommending a conditional ...

Read more →

Complexity in assessing the benefit versus risk of vaccines: experience with rotavirus and dengue virus vaccines

17 October 2019 - The remarkable contribution of immunisation programs to public health is recognised by most people, including those who ...

Read more →

First Algenex CrisBio-based vaccine submitted to European Medicines Agency

15 October 2019 - Potential approval would validate the use of Algenex’ CrisBio technology for the manufacture of recombinant subunit vaccines. ...

Read more →

Emergent BioSolutions receives EMA Prime Designation for its Chikungunya virus vaccine candidate

10 October 2019 - Emergent BioSolutions today announced that the company’s chikungunya virus (CHIKV) virus-like particle (VLP) vaccine candidate, CHIKV VLP, ...

Read more →

FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

24 September 2019 - The U.S. FDA announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...

Read more →

FDA accepts Merck’s biologics license application and grants priority review for V920, the company’s investigational vaccine for Ebola Zaire virus

17 September 2019 - Merck continues to expand investigational supply to support international Ebola outbreak response. ...

Read more →

I'm not in ...some Third World place': bladder cancer patients face ongoing scarcity of life-saving drug

16 September 2019 - Canada's only supplier, Merck, is now projecting BCG shortage will last until December 2020. ...

Read more →

FDA reiterates the importance of vaccines such as the Measles, Mumps, and Rubella (MMR) vaccine

6 September 2019 - The U.S. continues to experience cases and outbreaks of measles, largely due to unvaccinated or under-vaccinated segments ...

Read more →

Janssen announces U.S. FDA breakthrough therapy designation for investigational prophylactic vaccine for the prevention of respiratory syncytial virus in older adults

3 September 2019 - Janssen announced today that the U.S. FDA has granted breakthrough therapy designation for the Company's investigational ...

Read more →

Moderna receives FDA fast track designation for Zika vaccine mRNA-1893

19 August 2019 - Moderna today announced that the U.S. FDA has granted fast track designation for its investigational Zika vaccine ...

Read more →

Vas Narasimhan of Novartis: ‘we are not at all prepared for a pandemic’

1 August 2019 - The son of Indian immigrants read Greek philosophy and worked at McKinsey before joining a giant drug ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

New made-in-Canada technique could revolutionise vaccine transportation

21 May 2019 - Researchers in Ontario have developed a new method of transporting life-saving vaccines to remote and impoverished ...

Read more →

Emergent BioSolutions announces granting of marketing authorisation in Five EU countries for its oral typhoid vaccine; expands availability across Europe

20 May 2019 - Emergent BioSolutions announced today that it has successfully obtained marketing authorization for its oral typhoid vaccine Vivotif ...

Read more →

First FDA approved vaccine for the prevention of dengue disease in endemic regions

1 May 2019 - The U.S. FDA announced today the approval of Dengvaxia, the first vaccine approved for the prevention of ...

Read more →